FDA has just approved the expansion of Pfizer’s Xalkori treatment to include patients suffering from a rare mutated form of advanced non-small-cell lung cancer
According to a recent research conducted by Rutgers University and published in the Journal of Neuroscience, the drug RGFP966 primarily used to treat cancer, appears to have the potential to keep the brain cells alive and enhance memory.
Scientists have discovered a precursor to an important cancer drug in a common laboratory plant.
09 Aug '24 16:35PM
